Company registration number 08443360 (England and Wales)
QUANTUM LEAP SOLUTIONS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
QUANTUM LEAP SOLUTIONS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
QUANTUM LEAP SOLUTIONS LIMITED
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
500,000
500,000
Tangible assets
4
3,484
5,298
Investments
5
2
2
503,486
505,300
Current assets
Debtors
6
134,386
172,740
Cash at bank and in hand
42,350
41,439
176,736
214,179
Creditors: amounts falling due within one year
7
(27,867)
(45,708)
Net current assets
148,869
168,471
Total assets less current liabilities
652,355
673,771
Provisions for liabilities
(5,298)
Net assets
652,355
668,473
Capital and reserves
Called up share capital
8
613
613
Capital redemption reserve
164
164
Profit and loss reserves
651,578
667,696
Total equity
652,355
668,473
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
QUANTUM LEAP SOLUTIONS LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025
31 March 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 26 November 2025 and are signed on its behalf by:
Mr I M Heaney
Director
Company registration number 08443360 (England and Wales)
QUANTUM LEAP SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information
Quantum Leap Solutions Limited is a private company limited by shares incorporated in England and Wales. The registered office is Kings Parade, Lower Coombe Street, Croydon, Surrey, CR0 1AA.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes.
1.4
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date if the fair value can be measured reliably.
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated. In a departure from this accounting policy the directors have decided to maintain the development costs at residual value on the basis that the asset will continue to generate income for the foreseeable future.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Domain Name
10% - Straight line
Development Costs
20% - Straight line
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
QUANTUM LEAP SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and machinery
25% - Straight line
Fixtures, fittings & equipment
25% - Straight line
Computer equipment
25% - Straight line
1.6
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.7
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).
1.8
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.9
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
QUANTUM LEAP SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.10
Taxation
The tax expense represents the sum of the deferred tax.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.11
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
1.12
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.13
Share-based payments
In the case of options granted, fair value is measured by a Black-Scholes pricing model.
1.14
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
7
7
QUANTUM LEAP SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
3
Intangible fixed assets
Domain Name
Development Costs
Total
£
£
£
Cost
At 1 April 2024 and 31 March 2025
1,930
1,032,548
1,034,478
Amortisation and impairment
At 1 April 2024 and 31 March 2025
1,930
532,548
534,478
Carrying amount
At 31 March 2025
500,000
500,000
At 31 March 2024
500,000
500,000
4
Tangible fixed assets
Plant and machinery
Fixtures, fittings & equipment
Computer equipment
Total
£
£
£
£
Cost
At 1 April 2024
5,499
3,119
42,852
51,470
Additions
916
916
At 31 March 2025
5,499
3,119
43,768
52,386
Depreciation and impairment
At 1 April 2024
3,676
3,119
39,377
46,172
Depreciation charged in the year
811
1,919
2,730
At 31 March 2025
4,487
3,119
41,296
48,902
Carrying amount
At 31 March 2025
1,012
2,472
3,484
At 31 March 2024
1,823
3,475
5,298
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
2
2
QUANTUM LEAP SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
101,537
148,334
Corporation tax recoverable
15,913
7,960
Other debtors
16,936
16,446
134,386
172,740
7
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
102
10,929
Taxation and social security
25,159
28,785
Other creditors
2,606
5,994
27,867
45,708
8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary share of 1p each
47,750
47,750
477
477
Ordinary share - A of 1p each
13,638
13,638
136
136
61,388
61,388
613
613
9
Directors' transactions
At the year end, included in other creditors is an amount of £73 (2024: £73) due to a director of the company.
10
Share-based payment transactions
The company has a share option scheme for certain employees. The options are settled in equity once exercised. The scheme allows for the exercise of options subject to certain criteria, being an 'event' and subject to certain lengths of time. An event arises should the company ultimately be sold or listed and on the event occurring, the option holders have the right to exercise any options held.
QUANTUM LEAP SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
10
Share-based payment transactions
(Continued)
- 8 -
Number of share options
Weighted average exercise price
2025
2024
2025
2024
Number
Number
£
£
Outstanding at 1 April 2024 and 31 March 2025
18,148
18,148
40,000.00
40.00
Exercisable at 31 March 2025
18,148
18,148
40,000.00
40.00
The options outstanding at 31 March 2025 are 18,148.
2025-03-312024-04-01falsefalsefalse26 November 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMr I M HeaneyMr T HailstoneMr S Barry084433602024-04-012025-03-31084433602025-03-31084433602024-03-3108443360core:PatentsTrademarksLicencesConcessionsSimilar2025-03-3108443360core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-03-3108443360core:PatentsTrademarksLicencesConcessionsSimilar2024-03-3108443360core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-03-3108443360core:PlantMachinery2025-03-3108443360core:FurnitureFittings2025-03-3108443360core:ComputerEquipment2025-03-3108443360core:PlantMachinery2024-03-3108443360core:FurnitureFittings2024-03-3108443360core:ComputerEquipment2024-03-3108443360core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3108443360core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3108443360core:CurrentFinancialInstruments2025-03-3108443360core:CurrentFinancialInstruments2024-03-3108443360core:ShareCapital2025-03-3108443360core:ShareCapital2024-03-3108443360core:CapitalRedemptionReserve2025-03-3108443360core:CapitalRedemptionReserve2024-03-3108443360core:RetainedEarningsAccumulatedLosses2025-03-3108443360core:RetainedEarningsAccumulatedLosses2024-03-3108443360core:ShareCapitalOrdinaryShareClass12025-03-3108443360core:ShareCapitalOrdinaryShareClass12024-03-3108443360core:ShareCapitalOrdinaryShareClass22025-03-3108443360core:ShareCapitalOrdinaryShareClass22024-03-3108443360core:ShareCapitalOrdinaryShares2025-03-3108443360core:ShareCapitalOrdinaryShares2024-03-3108443360bus:Director12024-04-012025-03-3108443360core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108443360core:PatentsTrademarksLicencesConcessionsSimilar2024-04-012025-03-3108443360core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-04-012025-03-3108443360core:PlantMachinery2024-04-012025-03-3108443360core:FurnitureFittings2024-04-012025-03-3108443360core:ComputerEquipment2024-04-012025-03-31084433602023-04-012024-03-3108443360core:PatentsTrademarksLicencesConcessionsSimilar2024-03-3108443360core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-03-31084433602024-03-3108443360core:PlantMachinery2024-03-3108443360core:FurnitureFittings2024-03-3108443360core:ComputerEquipment2024-03-3108443360bus:OrdinaryShareClass12024-04-012025-03-3108443360bus:OrdinaryShareClass22024-04-012025-03-3108443360bus:OrdinaryShareClass12025-03-3108443360bus:OrdinaryShareClass12024-03-3108443360bus:OrdinaryShareClass22025-03-3108443360bus:OrdinaryShareClass22024-03-3108443360bus:AllOrdinaryShares2025-03-3108443360bus:AllOrdinaryShares2024-03-31084433602023-03-3108443360bus:PrivateLimitedCompanyLtd2024-04-012025-03-3108443360bus:FRS1022024-04-012025-03-3108443360bus:AuditExemptWithAccountantsReport2024-04-012025-03-3108443360bus:Director22024-04-012025-03-3108443360bus:Director32024-04-012025-03-3108443360bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3108443360bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP